DERIVATIVES OF BENZOXAZEPINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND THEIR USING AS AGONISTS OF AMPA RECEPTOR Russian patent published in 2006 - IPC C07D498/04 C07D515/04 A61K31/553 A61K31/554 A61P25/00 

Abstract RU 2279434 C2

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to derivatives of benzoxazepine and describes derivative of benzoxazepine of the general formula (I): wherein X represents -CO or -SO2; R1, R2, R3 and R4 are chosen independently from hydrogen atom (H), (C1-C4)-alkyl, (C1-C4)-alkoxy-group, (C1-C4)-alkyloxy-(C1-C4)-alkyl, -CF3, halogen atom, nitro-group, cyano-group, -NR8R9, -NR8COR10 and -CONR8R9; R5, R6 and R7 represent independently hydrogen atom (H) or (C1-C4)-alkyl; R8 and R9 represent independently hydrogen atom (H) or (C1-C4)-alkyl; or R8 and R9 in common with nitrogen atom to which they are bound form 5- or 6-membered saturated heterocyclic ring comprising optionally the additional heteroatom chosen from oxygen atom (O), sulfur atom (S) or the group -NR11; R10 represents (C1-C4)-alkyl; R11 represents (C1-C4)-alkyl; A represents residue of 4-7-membered saturated heterocyclic ring comprising optionally oxygen atom wherein ring is substituted optionally with 1-3 substitutes chosen from (C1-C4)-alkyl, (C1-C4)-alkoxy-, hydroxy-group, halogen atom and oxo-group, or to its pharmaceutically acceptable salt under condition that compounds of the formula (I) are excluded wherein X represents -CO, and each among R1-R7 represents hydrogen atom (H), and A represents -(CH2)3 or -(CH2)4; compounds of the formula (I) wherein X represents -CO; R1 represents hydrogen atom (H); R2 represents methyl (CH3); each among R3-R7 represents hydrogen atom (H), and A represents -(CH2)3; compounds of the formula (I) wherein X represents -CO; R1 and R2 represent hydrogen atom (H); R3 represents methyl; each among R4-R7 represents hydrogen atom (H), and A represents -(CH2)3; compounds of the formula (I) wherein X represents -CO; each among R1-R3 represents hydrogen atom (H); R4 represents methyl; each among R5-R7 represents hydrogen atom (H), and A represents -(CH2)3, and compounds of the formula (I) wherein X represents -CO; each among R1-R4 represents hydrogen atom (H); R5 represents methyl; R6 and R7 represent hydrogen atom (H), and A represents -(CH2)3. Also, invention describes pharmaceutical compositions comprising indicated derivatives and using these benzoxazepine derivatives in treatment of neurological diseases and psychotic disorders sensitive to enhancing responses mediated by AMPA receptors in the central nervous system. Invention provides preparing new compounds possessing the useful biological properties.

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.

8 cl, 1 tbl, 31 ex

Similar patents RU2279434C2

Title Year Author Number
(PYRIDO/THIENO)[f]OXAZEPINE-5-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED ON THE SAME AND METHOD FOR TREATMENT OF NEUROLOGICAL DISEASES OR MENTAL DISORDERS 2002
  • Gruv Sajmon Dzhejms Ehntoni
  • Ehdam-Uorrall Dzhulija
  • Chzhang Mingtsjan
  • Gilfillan Robert
RU2286347C2
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF 2015
  • Gaillard, Pascale
  • Seenisamy, Jeyaprakashnarayanan
  • Gardberg, Anna
  • Johnson, Theresa L.
  • Sherer, Brian A.
  • Goutopoulos, Andreas
  • Won, Annie Cho
  • Jones, Reinaldo
  • Neagu, Constantin
  • Qiu, Hui
  • Caldwell, Richard D.
  • Potnick, Justin
  • Liu-Bujalski, Lesley
RU2742122C2
DERIVATIVE OF 1-[(INDOLE-3-YL)CARBONYL]PIPERAZINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND ITS USING 2003
  • Kouli Fillip Martin
  • Kolfild Uilson
  • Tirni Dzhehjson
  • Kehrns Dzhejms
  • Adam-Uorrell Dzhulija
  • Jork Mark
RU2318821C2
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF 2016
  • Patel Snakhel
  • Gamilton Gregori
  • Stivala Krejg
  • Chen Khuejfen
  • Chzhao Gujlin
RU2716136C2
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) 2018
  • Eriksson, Anna
  • Grin, Nil
  • Gustafson, Gari
  • Khan, Binsun
  • Lanchia, Ml. Devid R.
  • Mitchell, Lorna
  • Richard, Devid
  • Shelekhin, Tatyana
  • Smit, Chejz K.
  • Van, Chzhungo
  • Chzhen, Syaochzhan
RU2736217C2
TRICYCLIC DIAZEPINE VASOPRESSIN AND OXYTOCIN ANTAGONISTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT 1994
  • Dzhej D.Olbrajt
  • Mehrvin F.Rejch
  • Fuk-Vakh Sam
  • Ehfren Gil'Ermo Delos Santos
RU2126006C1
PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF 2014
  • Lyuj Khetszyun
  • Sun Pyaoyan
  • Guj Bin
  • Dun Tsin
RU2674977C2
NON-STEROIDAL MODULATORS OF PROGESTERONE RECEPTOR 2003
  • Khermkens Pedro Kharol'D Khan
  • Lukas Khans
  • Dols Pol' Peter Mari Antonius
  • Revinkel Jokhannes Bernardus Marija
  • Folmer Brigit Jokhanna Bernita
RU2309155C2
METHOD FOR PREPARING 6-ALKYLIDENEPENEM DERIVATIVES 2003
  • Abe Takao
  • Matsunaga Khirosi
  • Mikhira Ado
  • Sato Tisato
  • Usirogoti Khideki
  • Sato Koiti
  • Takasaki Tsujosi
  • Venkatesan Aranapakam Mudumbaj
  • Mansour Tarek Sukhajl
RU2317297C2
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS 2013
  • Hu, Shaojing
  • Wang, Fei
  • Xu, Zhiguo
  • Wang, Yinxiang
  • Wang, Yanping
RU2619130C2

RU 2 279 434 C2

Authors

Gruv Sajmon Dzhejms Ehntoni

Chzhang Mingtsjan

Shakhid Mokhammad

Dates

2006-07-10Published

2002-06-05Filed